LUIS GONZAGA
PAZ-ARES RODRÍGUEZ

Profesor titular de universidad

Foto de LUIS GONZAGA

Foto de Princess Margaret Cancer Centre

Princess Margaret Cancer Centre

Toronto, Canadá

Publications in collaboration with researchers from Princess Margaret Cancer Centre (5)

2022

Isatuximab plus atezolizumab in patients with advanced solid tumors: results from a phase I/II, open-label, multicenter study
ESMO Open, Vol. 7, Núm. 5

2017

Outcomes in patients with aggressive or refractory disease from REVEL: A randomized phase III study of docetaxel with ramucirumab or placebo for second-line treatment of stage IV non-small-cell lung cancer
Lung Cancer, Vol. 112, pp. 181-187
Phase II trial of atezolizumab as first-line or subsequent therapy for patients with programmed death-ligand 1-selected advanced non-small-cell lung cancer (BIRCH)
Journal of Clinical Oncology

2016

Novel active agents in patients with advanced NSCLC without driver mutations who have progressed after first-line chemotherapy
ESMO Open, Vol. 1, Núm. 6

2015

A Phase Ib dose-escalation study of the oral pan-PI3K inhibitor buparlisib (BKM120) in combination with the oral MEK1/2 inhibitor trametinib (GSK1120212) in patients with selected advanced solid tumors
Clinical Cancer Research, Vol. 21, Núm. 4, pp. 730-738